Northwestern Nanodiamonds Kill the Cancer Left Behind
Scientists at Northwestern University develop a nanodevice that delivers drugs to residual cancer cells left in the body after tumor surgery.
click here to read full article...Wistar Maps Telomerase Enzyme Present in Most Cancers
Scientists map the structure of a key enzyme found in over 90 percent of human cancers. Their discovery could lead to treatments with fewer side effects.
click here to read full article...KRAS is Key to Choosing Colorectal Cancer Chemotherapy
Picking the right drugs to treat colon cancer may depend on the type of KRAS genes in the tumor. Experts are now saying advance testing is the way to go.
click here to read full article...MIT: Striped Nanoparticles Can Deliver Drugs Inside Cells
MIT creates striped nanoparticles that can deliver cargo inside a cell’s cytosol without killing it — big news for those developing targeted cancer treatments.
click here to read full article...Metformin May Boost Response to Breast Cancer Chemo
An MD Anderson study shows women taking a common diabetic drug are likelier to be cancer-free after neoadjuvant breast cancer chemotherapy than those who don’t.
click here to read full article...Polymer Slime Protects Cancer-Killing Nanoworms
Two California universities and MIT team up to create a polymer-protected nanoworm that may one day make it possible to deliver cancer drugs directly to tumors.
click here to read full article...Lipidoids Could Deliver RNAi Treatments Directly to Cancer
Scientists from the Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) have discovered a method which makes it possible to deliver powerful RNA interference (RNAi) therapies directly to the precise location where cancer or viral infections are developing. RNAi therapies are designed to turn on and off disease-causing genes. Early RNAi studies [...]
click here to read full article...Prostate Cancer Treatment Effectiveness Could Rely on P53
A study led by the Fred Hutchinson Cancer Research Center suggests that tumors with intact P53 genes may respond better to prostate cancer treatments designed to target insulin-like growth factor 1 receptors (IGF-1R). Fred Hutchinson’s findings could have an important impact on more than a dozen clinical trials currently being conducted to test IGF-1R inhibitors. [...]
click here to read full article...Mayo Clinic Oncologists Answer Cancer Questions Online
One of the top cancer treatment facilities in the world is offering you the opportunity to e-mail your questions about cancer to their oncology experts. The Mayo Clinic web site has a feature called Ask a Cancer Specialist which allows anybody with internet access the chance to ask Mayo’s experienced specialists their tough cancer questions [...]
click here to read full article...Anal Cancer Survivor is Fertile Again After Ovarian Implants
German physicians have successfully used ovarian tissue implants to restore fertility to a 32-year-old cancer survivor who lost her ability to get pregnant after receiving treatments for anal cancer. Knowing the tumor’s close proximity to reproductive organs increased the possibility of infertility, doctors at Erlangen University Hospital removed healthy ovarian tissue from the young woman [...]
click here to read full article...
